Liberty Mutual Group Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-40,724
Closed -$960K – 546
2018
Q3
$960K Sell
40,724
-15,716
-28% -$384K 0.02% 400
2018
Q2
$1.3M Hold
56,440
– – 0.03% 258
2018
Q1
$1.39M Sell
56,440
-7,360
-12% -$193K 0.04% 242
2017
Q4
$1.71M Buy
63,800
+48,200
+309% +$1.23M 0.05% 223
2017
Q3
$376K Buy
+15,600
New +$353K 0.02% 859
2016
Q1
– Sell
-52,606
Closed -$1.53M – 1007
2015
Q4
$1.53M Hold
52,606
– – 0.06% 480
2015
Q3
$1.43M Sell
52,606
-800
-1% -$22.7K 0.05% 671
2015
Q2
$1.46M Hold
53,406
– – 0.05% 718
2015
Q1
$1.43M Sell
53,406
-1,296
-2% -$29.8K 0.04% 761
2014
Q4
$1.16M Sell
54,702
-18,150
-25% -$405K 0.04% 804
2014
Q3
$1.74M Buy
+72,852
New +$1.68M 0.06% 580

Other funds holding NVO

Liberty Mutual Group Asset Management's NVO Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 40,724 shares — an estimated $960K sold.

Liberty Mutual Group Asset Management first reported a position in NVO in Q3 2014 and held it in 11 quarters. The position peaked at $1.74M in Q3 2014. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

  • Liberty Mutual Group Asset Management reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 40,724 Novo Nordisk shares in Q4 2018, an estimated $960K.
  • Liberty Mutual Group Asset Management first reported a position in Novo Nordisk in Q3 2014 and held it in 11 quarters.
  • Liberty Mutual Group Asset Management's Novo Nordisk position peaked at $1.74M in Q3 2014.
  • 550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.